ZPK urged to create more fair competition

Zuellig Pharma Korea (ZPK) should not interfere with its domestic wholesalers’ efforts to make direct dealing with multinational companies, the Korean Pharmaceutical Association (KPA) in October 25 statement.

The statement said that ZPK will have to make more fair completion with domestic wholesalers, while its obstruction against local wholesaler’s direct traction with foreign pharmaceutica...